This document discusses the changing digital landscape and its implications for doctors, patients, and medical representatives. It notes that digital experiences are now configurable, immersive, thought-provoking, and relevant. It states that doctors want specialized information, patients want tailored information, and reps want doctor and learning needs-specific information. However, in the digital world there is also information overload. The document argues that for medical reps to be effective in this environment, they need to become "digital collaborators," serving as information editors and technology partners for doctors. It provides examples of Novartis empowering reps through digital strategies and the challenges of shifting to more interactive and decentralized models of information sharing.
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
Digital Pharma: Evolution and Revolution in Marketing & SalesLen Starnes
A review for non-pharma audiences of evolutionary and revolutionary changes in pharma marketing and sales since the mid 90s. Presented at ENG's Effective Web Marketing and Search Engine Marketing conference, Brussels, November, 2007.
My talk during the Digital4 Pharma conference, July 2016 in Greece. My talk described the digital transformation of Takeda with our vision and how Takeda Pharmaceutical explore initiatives and trends in order to provide better services to healthcare professionals. Virtual Reality was one of the experiments which Takeda Hellas implemented in the framework of digital new way of thinking. Key findings are cross-functional collaboration, focus on the objectives and needs of our HCPs. Conclusion: if we benefit from the combination of the technology and traditional marketing aspects then the results will be a good mix of creative and quality actions .
How Many Doctors in India Online?
What Indian Doctors Do Online?
Where Do They Need Help?
What are the Communication opportunities for Pharma?
How will e-Doctors evolve down the stream and how can Pharma stay Relevant?
Answers to all these questions and a case study of CiplaMed (a physician only community website started by Cipla Pharmaceuticals in 2008)
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
Digital Pharma: Evolution and Revolution in Marketing & SalesLen Starnes
A review for non-pharma audiences of evolutionary and revolutionary changes in pharma marketing and sales since the mid 90s. Presented at ENG's Effective Web Marketing and Search Engine Marketing conference, Brussels, November, 2007.
My talk during the Digital4 Pharma conference, July 2016 in Greece. My talk described the digital transformation of Takeda with our vision and how Takeda Pharmaceutical explore initiatives and trends in order to provide better services to healthcare professionals. Virtual Reality was one of the experiments which Takeda Hellas implemented in the framework of digital new way of thinking. Key findings are cross-functional collaboration, focus on the objectives and needs of our HCPs. Conclusion: if we benefit from the combination of the technology and traditional marketing aspects then the results will be a good mix of creative and quality actions .
How Many Doctors in India Online?
What Indian Doctors Do Online?
Where Do They Need Help?
What are the Communication opportunities for Pharma?
How will e-Doctors evolve down the stream and how can Pharma stay Relevant?
Answers to all these questions and a case study of CiplaMed (a physician only community website started by Cipla Pharmaceuticals in 2008)
A summary of macro level trends and issues that are driving the need for enhanced digital marketing and service delivery in the Pharma/Healthcare industry. Included are case studies presented at the recent ePharm Summit in NYC.
Pharma Digital Marketing - 5 future trendsmarcmunch2014
Digital Marketing within the Pharma Industry:
The first and safer way is to summarize the past 12 months, the second, more dangerous but also more exciting is to predict what will happen in 2015.
For years digital marketing was treated as a fifth wheel in pharma business. Whatever we say, the truth is that those organisations are made of sales force. And a digital sales force was just another marketing gimmick that does not add value but a workload and cost.
However, during past few years this traditional sales force thinking was challenged. Payers pressure forced companies to reduce ranks of sales representatives. Regulatory decisions have limited possibility of sales rep to meet HCPs. The result is that sales rep cannot meet his Client often enough to detail the product and maintain relationship in the same time.
Digital came to help with e-detailing and web-based self-detail solutions. CRM software supports reps with data that allow reps to have a meaningful conversation with HCPs they barely know.
Combining detailing visits with digital tatics and good old direct marketing is our new buzz word: Multi Channel Marketing or Multi Channel Sales
Digital marketing for pharmaceutical companiesdigitalsaline
“I think the biggest innovations of the 21st Century will be at the intersection of Biology and technology. A new era is beginning” –Steve Jobs
Like all other businesses, the healthcare and pharmaceutical industry is also looking keenly at digital for enhancing and marketing their products. Social media and mobile apps are set to play a bigger role in the growth of this business. This will help people to catch up with tech-savvy emerging markets peers, approximately half the pharmaceutical companies are expected to allocate more than a fifth of their marketing budget to digital marketing by 2019.
Website and applications for medical knowledge sharing such as Knowledge Genie to those having on virtual and augmented reality to engage with doctors and patients, Pharmaceutical industries are getting their marketing strategy aligned to digital prospects.
5 ways to succeed with digital pharma marketingJo Peddhinti
Go beyond your average webinars and banner ads. Discover innovative ways to improve your digital marketing strategy. Set your brand apart from competition and improve your ROI.
The aim of this presentation is to help Digital Marketing managers to implement an efficient e-marketing strategy in the particular and constrained environment of the pharmaceutical industry. This presentation can also be a good opportunity for Operational Marketing professionals jammed with the traditional 4p to realise that implementing a 360° marketing strategy is not only aligning Web and Marketing (or vice versa).
I took the opportunity of the success of my previous release to enhance and complete some slides in this V2.0. You will discover how a Biopharmaceutical company (Celgene) has taken a good start after my advises in 2010 and how they have implemented an e-marketing strategy with the evolution of their Internet portals and their connections to medical portals.
It seems to me that you can significantly improve your knowledge of e-marketing tactics with free tools in order to audit and monitor your consumer’s behaviours in the digital space by reading my other presentation: Digital Marketing Management.
It is all about the Digital and Social Media in Pharma industry with special reference to India. In this described physicians preference with the key digital indicator of India. In this also given the list of top 10 companies in Indian pharma sector. At the end, Case-study of Pfizer is also described...
Pharma Marketing Digital Trends to Watch in 2020. A closer look at some of the future directions that Pharma Marketing need in 2020 to arm themselves for in full readiness for the next 12 Months
The health care industry is lagging other industry sectors when it comes to customer-centric thinking in the age of digital, according to a new report by Adobe Digital Insights (ADI), which looks at how consumers are responding to the online tools at their disposal for managing health care.
Many pharmaceutical companies face the same pain points when it comes to designing, implementing and employing CLM digital platforms. In this whitepaper we explore the challenges CLM poses for the pharma industry and how digital providers and their solutions need to address these pain points.
E-Marketing in the Pharmaceutical Industry (a student presentation)SunnyShah
As a way of giving back to our university, The University of the Sciences in Philadelphia, Dominic, Rina, and myself gave a presentation about "e-Marketing in the Pharmaceutical Industry".
All points taken from this presentation were only used by students for educational purposes and much of the information was gathered from the 8th annual ePharma Summit that we went to.
Personalized HCP Marketing: How to Create More Impactful Brand ExperiencesMerkle
At this year's ePharma 2015 Conference, Croom Lawrence, Senior Director, Digital, Merkle Health, shared the importance of personalization for healthcare consumers and physicians. In his presentation, Croom discussed how an Addressable Customer Experience strategy can create more impactful brand experiences.
#ChatAfib: Pharma industry's first-ever open tweet chatLen Starnes
Analysis of the pharma industry's first.ever tweet chat: Boehringer Ingelheim's #ChatAfib, staged during the 2013 European Society of Cardiolgy Congress. The first of two presentations exploring the impact of social media and digital technologies on professional medical conferences
Mobile Trends in Pharma & Healthcare Advertising | Silverlight Digital lorigo
Seventy percent of Internet use is now on mobile — and taking market share from other platforms. Adapted from a live presentation from Google NY’s Mobile Trends in Pharma & Healthcare Advertising Event, Silverlight Digital explores key trends that pharma and healthcare advertisers must take advantage of to increase performance in today's marketplace.
During our SHSMD Connections 2015 solutions spotlight session, Bluespire healthcare and digital strategists discussed how organizations across the country are analyzing data and improving patient engagement, while simultaneously making experiences more personalized.
Cultivating Pharma Patient Relationships in the Digital EraPerficient, Inc.
Patients are more empowered than ever to be advocates for their own health, which has led to a dramatic shift in their expectations of pharmaceutical and medical device companies. Patients now expect these companies to provide them with the kind of personalized advice, support, and tools they used to only get from their physicians.
This shift has created a unique opportunity for life sciences organizations to develop a direct relationship with the consumers of their products. In this SlideShare, Param Singh, director of clinical operations solutions at Perficient, shows how organizations can use strategy, technology, and design to establish themselves as an integral part of a patient’s health.
The 50 Best Companies to Watch 2018, we have listed the best companies who are praised worldwide for transforming the entire business network to the next level. On the Cover of the issue, we have Cannabis Science: Providing Innovative Therapeutics for Unmet Medical Needs.
A summary of macro level trends and issues that are driving the need for enhanced digital marketing and service delivery in the Pharma/Healthcare industry. Included are case studies presented at the recent ePharm Summit in NYC.
Pharma Digital Marketing - 5 future trendsmarcmunch2014
Digital Marketing within the Pharma Industry:
The first and safer way is to summarize the past 12 months, the second, more dangerous but also more exciting is to predict what will happen in 2015.
For years digital marketing was treated as a fifth wheel in pharma business. Whatever we say, the truth is that those organisations are made of sales force. And a digital sales force was just another marketing gimmick that does not add value but a workload and cost.
However, during past few years this traditional sales force thinking was challenged. Payers pressure forced companies to reduce ranks of sales representatives. Regulatory decisions have limited possibility of sales rep to meet HCPs. The result is that sales rep cannot meet his Client often enough to detail the product and maintain relationship in the same time.
Digital came to help with e-detailing and web-based self-detail solutions. CRM software supports reps with data that allow reps to have a meaningful conversation with HCPs they barely know.
Combining detailing visits with digital tatics and good old direct marketing is our new buzz word: Multi Channel Marketing or Multi Channel Sales
Digital marketing for pharmaceutical companiesdigitalsaline
“I think the biggest innovations of the 21st Century will be at the intersection of Biology and technology. A new era is beginning” –Steve Jobs
Like all other businesses, the healthcare and pharmaceutical industry is also looking keenly at digital for enhancing and marketing their products. Social media and mobile apps are set to play a bigger role in the growth of this business. This will help people to catch up with tech-savvy emerging markets peers, approximately half the pharmaceutical companies are expected to allocate more than a fifth of their marketing budget to digital marketing by 2019.
Website and applications for medical knowledge sharing such as Knowledge Genie to those having on virtual and augmented reality to engage with doctors and patients, Pharmaceutical industries are getting their marketing strategy aligned to digital prospects.
5 ways to succeed with digital pharma marketingJo Peddhinti
Go beyond your average webinars and banner ads. Discover innovative ways to improve your digital marketing strategy. Set your brand apart from competition and improve your ROI.
The aim of this presentation is to help Digital Marketing managers to implement an efficient e-marketing strategy in the particular and constrained environment of the pharmaceutical industry. This presentation can also be a good opportunity for Operational Marketing professionals jammed with the traditional 4p to realise that implementing a 360° marketing strategy is not only aligning Web and Marketing (or vice versa).
I took the opportunity of the success of my previous release to enhance and complete some slides in this V2.0. You will discover how a Biopharmaceutical company (Celgene) has taken a good start after my advises in 2010 and how they have implemented an e-marketing strategy with the evolution of their Internet portals and their connections to medical portals.
It seems to me that you can significantly improve your knowledge of e-marketing tactics with free tools in order to audit and monitor your consumer’s behaviours in the digital space by reading my other presentation: Digital Marketing Management.
It is all about the Digital and Social Media in Pharma industry with special reference to India. In this described physicians preference with the key digital indicator of India. In this also given the list of top 10 companies in Indian pharma sector. At the end, Case-study of Pfizer is also described...
Pharma Marketing Digital Trends to Watch in 2020. A closer look at some of the future directions that Pharma Marketing need in 2020 to arm themselves for in full readiness for the next 12 Months
The health care industry is lagging other industry sectors when it comes to customer-centric thinking in the age of digital, according to a new report by Adobe Digital Insights (ADI), which looks at how consumers are responding to the online tools at their disposal for managing health care.
Many pharmaceutical companies face the same pain points when it comes to designing, implementing and employing CLM digital platforms. In this whitepaper we explore the challenges CLM poses for the pharma industry and how digital providers and their solutions need to address these pain points.
E-Marketing in the Pharmaceutical Industry (a student presentation)SunnyShah
As a way of giving back to our university, The University of the Sciences in Philadelphia, Dominic, Rina, and myself gave a presentation about "e-Marketing in the Pharmaceutical Industry".
All points taken from this presentation were only used by students for educational purposes and much of the information was gathered from the 8th annual ePharma Summit that we went to.
Personalized HCP Marketing: How to Create More Impactful Brand ExperiencesMerkle
At this year's ePharma 2015 Conference, Croom Lawrence, Senior Director, Digital, Merkle Health, shared the importance of personalization for healthcare consumers and physicians. In his presentation, Croom discussed how an Addressable Customer Experience strategy can create more impactful brand experiences.
#ChatAfib: Pharma industry's first-ever open tweet chatLen Starnes
Analysis of the pharma industry's first.ever tweet chat: Boehringer Ingelheim's #ChatAfib, staged during the 2013 European Society of Cardiolgy Congress. The first of two presentations exploring the impact of social media and digital technologies on professional medical conferences
Mobile Trends in Pharma & Healthcare Advertising | Silverlight Digital lorigo
Seventy percent of Internet use is now on mobile — and taking market share from other platforms. Adapted from a live presentation from Google NY’s Mobile Trends in Pharma & Healthcare Advertising Event, Silverlight Digital explores key trends that pharma and healthcare advertisers must take advantage of to increase performance in today's marketplace.
During our SHSMD Connections 2015 solutions spotlight session, Bluespire healthcare and digital strategists discussed how organizations across the country are analyzing data and improving patient engagement, while simultaneously making experiences more personalized.
Cultivating Pharma Patient Relationships in the Digital EraPerficient, Inc.
Patients are more empowered than ever to be advocates for their own health, which has led to a dramatic shift in their expectations of pharmaceutical and medical device companies. Patients now expect these companies to provide them with the kind of personalized advice, support, and tools they used to only get from their physicians.
This shift has created a unique opportunity for life sciences organizations to develop a direct relationship with the consumers of their products. In this SlideShare, Param Singh, director of clinical operations solutions at Perficient, shows how organizations can use strategy, technology, and design to establish themselves as an integral part of a patient’s health.
The 50 Best Companies to Watch 2018, we have listed the best companies who are praised worldwide for transforming the entire business network to the next level. On the Cover of the issue, we have Cannabis Science: Providing Innovative Therapeutics for Unmet Medical Needs.
The New Rules Of Doctor Engagement in the New Normal
2020, which could very well be the year of the coronavirus, has been witnessing drastic disruptions with enforced lockdowns, social distancing, new patient demands and healthcare systems put under extraordinary pressures. The pandemic has worsened the pharma market in India and is expected to lead the country towards a major slowdown.
Challenges that have arised
> Doctors not ready to meet MRs
> No physical events possible
> Virtual events doesn't give FaceTime with doctors
#DIGITALMARKETING #PHARMAMARKETING #DOCTORMARKETING #HOSPITALMARKETING #HEALTHCAREMARKETING #RELEVANTINTERACTIONS
Generic Pharma at Strategic Inflection Point - IHF - CEO Nicos RossidesMedochemie Ltd
Medochemie CEO Dr Nicos Rossides argued that generic pharma is at a strategic inflection point due to a combination of factors: on the one hand are industry forces such as price pressure, tough regulatory/legislative environment, shifting demographics and increasing patient empowerment. On the other hand, the digital revolution has far reaching implications on the way in which generic pharma companies create and deliver value.
Numa era de mudanças organizacionais e perturbações globais sem precedentes, o relatório Global Marketing Trends 2022 apresenta as principais tendências de marketing, fruto dos desafios de negócio que enfrentamos
HealthXL Digital Health Success Stories Report Part OneMaeve Lyons
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report is now available and delves into some of the recent successes in medical tech and asks the experts what it all means.
Key Points:
Multi-million dollar investments don’t always mean success. Success looks different to each stakeholder involved in digital health.
The winners in digital health will be those who provide real solutions to problems at a reduced cost.
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report comprises an in-depth view of the progress of digital health, case studies, along with opinion from some key players in the industry.
Digital health empowers us with ways to improve outcomes and increase efficiency.
Part 2 of our report will look at how we can learn from failures in digital health, available [when available and how to access].
An introduction to Digital Marketing for the Healthcare IndustryMurad Quandour
I work with a great deal of small to medium sized clinics with no dedicated marketing, sales, or communications professionals, who are always looking for ways to improve their businesses discoverability.
This is their introduction to the digital marketing world and a good place to explain the basic general areas of digital interests.
Medicare Marketing in Our Digital World- The definitive digital marketing han...Scott Levine
Read the entire 43 page ebook now or download it here.
http://ow.ly/Y2st30csWl9
Medicare Marketers Are Struggling to Develop Digital Marketing Strategy
n the new digital economy, we are in the midst of a third industrial revolution comparable in scale and impact to the introduction of electrification. Digital technology has the potential to improve corporate performance and reach radically, leading to demonstrably better financial performance. However, while the potential of digital is clear, how to practically deliver on a digital vision is less so. In this third Digital Transformation Review, we aim to help business leaders understand more about the managerial and change challenge that they are facing. We look at how an organization defines its digital vision, how to drive change through effective governance and a people strategy, and how to seize the opportunity offered by big data.
We also offer a fresh perspective from pioneers across the globe, looking at an Indian organization’s approach to innovation in healthcare. One company that has defined an ambitious digital vision is Pfizer. We interview Kristin Peck, executive VP of worldwide business development and innovation, and John Young, president and general manager of the primary care business unit, who share the opportunities they see in the digital space as well as their journey in transforming their organization to create more value for their customers.
Digital Health Success Stories Report - Part 1Tom Parsons
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report is now available and delves into some of the recent successes in healthcare technology and asks the experts what it all means.
The Future of Marketing: Seizing the Customer ExperienceMarketo
86% of CMOs and senior marketing executives believe they will own the end-to-end customer experience by 2020.
Watch our sponsored webinar to learn why you should never leave the side of your customer on their buying journey and how to prepare for a customer-centric future. We’ll share insights from top CMOs, revealed in new research from The Economist Intelligence Unit, on how they expect to:
- Leverage data and technology to understand customers’ behavior
- Personalize the customer experience through top marketing channels (and how innovative brands are already succeeding)
- Boost their brand value by delivering a better experience
Big data e social media nel Pharma - IMS Health Italia @Aboutpharma Digital S...IMS Health Italia
Social media e Pharma sono inconciliabili?
Ne abbiamo parlato come keynote speaker al Digital Summit di Aboutpharma del'8 giugno 2016, dimostrando come un'azienda farmaceutica utilizzando gli strumenti giusti possa seguire tutto quanto è pubblicato online ed estrarre da questi big (real-world ) data tutto il valore.
You are your content - Being here, now: State of content 2017Accenture Insurance
Our relationship to content has been transformed. So many aspects of our lives, big and small, are lived online. From education to recreation, one is hard-pressed to identify aspects of modern life not changed by digital content. This second annual study from Accenture Interactive surveyed over 1,000 executives from 14 countries and 18 industries to understand this shifting paradigm, and to help organizations respond.
Content must be a vital expression of an organizations purpose, and true to its lifeblood. Content is how the organization expresses itself. In this hyper-connected age, You are Your Content, it is the voice of your organization. And so, it is no surprise that organizations are beginning to want to own that voice, building new in-house capabilities, innovating in distribution channels, focusing on quality, and establishing stewardship at the most senior levels of the organization in order to be everywhere for their audiences.
What can healthcare learn from the transformation which have taken place in other industries? What is the potential of digital for the pharmaceutical companies of tomorrow?
Webinar materials prepared for Association for Community-Affilitated Plans (ACAP). Healthcare consumerism is coming - are you prepared? As industry changes, so consumers adapt, and today's consumers have a world of information and engagement tools at their fingertips. In this webinar, learn how health insurance organizations and other healthcare companies can increase and improve their consumer experience through meaningful engagement, through social media.
The 10 most trusted diagnostics and pathology center.Merry D'souza
Inquisitiveness is a primary trait of human beings. The human brain which processes millions of thoughts in a flash of time needs to know about everything and anything around it. Human well being or fitness is one such area that has grown by leaps and bound over centuries given to the human quest to stay healthy. Specific to it is the study of diseases, their cause and effect which comes under the broad spectrum of Pathology.
With a focus on providing high-quality, lower-cost care, the healthcare industry has been looking to the retail industry for strategies used to engage and empower consumers. Lessons learned include how to use the retail setting as a medium for providing care and how to engage consumers outside of the care setting by using technology.
What is often neglected when assessing retail industry tactics is their core competency of using data insights to motivate and incentivize changes in consumer behavior. Connected Health solutions provide streams of valuable information that can be mined and analyzed to achieve business objectives.
Perficient's healthcare and retail experts demonstrated how data can be leveraged to:
-Transform passive recipients of care into active participants in care
-Mass customize messaging aligned with population health initiatives
-Achieve outreach objectives that convert unknown consumers into patients/members
-Improve care and lower healthcare costs
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...Anup Soans
Key Point from the Q &A with Dr. Mandar Kubal, Mumbai
Telemedicine has become a very useful tool for clinicians to manage their patients.
Given the ever changing contours of Covid19 treatment, doctors have to check daily for online resources.
It would be wonderful if pharma can provide every specialty the latest developments in treating Covid19 with pre existing conditions instead of sending their unvaccinated field force to give brand reminders.
Pharma should seek frontline worker status for Medical Reps and Field Managers as they are critical to maintain the drug supply chain.
Treat the Field Force as an asset and protect them, instead of pushing them onto the field without vaccination.
And many more insights from a clinician at the frontlines of treating Covid19 patients.
Now on MedicinMan YouTube Channel - https://youtu.be/J_p3paeO_eg
Key Challenges Facing Pharma Industry and the Way ForwardAnup Soans
Suresh Subramanian, pharma veteran discusses Key Challenges Facing Pharma Industry and the Way Forward on Saturday, 27th March at 6 PM on https://www.credoweb.in/discussion/630/key-challenges-facing-pharma-industry-and-the-way-forward
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thAnup Soans
Covid-19 has hugely affected the modes of interaction between physicians and pharma Sales Force.
As of February 2021, most pharma companies in India re-started their F2F visits even though most corporate hospitals have restricted access to salesforce
What is keeping most CEOs awake – How to respond to customer expectations and adjust the content and format accordingly.
How to track complexities of implementation of a new model into marketing & sales teams.
Many research reports have indicated that a hybrid (mixed model) that includes face to face and digital interactions are favoured by most respondent Physicians.
The other challenge is the need to change the outdated traditional digital model, which is overused and creates digital noise into an innovative interactive model.
Register Now: https://lnkd.in/gmJK8et
Key Account Management - Time for India Pharma to Adopt KAMAnup Soans
Pharma's 40-year Model of Pitching to the HCPs is Over says Hanno Wolfram author of Key Account Management in Pharma...
Watch the webinar on Digital Excellence Pharma Academy today at 6 PM to know more - https://lnkd.in/gjZRN6q
How can Pharma Use Digital to Engage Doctors and Understand PatientsAnup Soans
Doctors and patients are already using digital for many healthcare needs. Telemedicine is a prime example.
A Webinar by Dr. Shenoy Robinson today at 6 PM on - https://www.credoweb.in/discussion/604/how-can-pharma-use-digital-to-engage-doctors-and-understand-patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
Why Indian Pharma Needs to Enable Managers to Develop TalentAnup Soans
People need the support of their leaders and organisations processes to develop their talents.
Deep Bhandari delves deep into the topic of Talent Development and its impact on individuals and organisations.
Digital Excellence Pharma Academy Certification ProgramAnup Soans
Now on YouTube: Gartner's Top Five Priorities for Pharma Business Leaders and @Hariram K's Key Learning Points on Leadership
25-minute discussion with Deep Bhandari on the Gartner Report and Leadership Imperatives by Hariram Krishnan on How the DEPA Certification Program Can Make Pharma Professionals Future Proof
https://lnkd.in/gHiT_WU via @YouTube
Architecture To Develop Pharma Business Leaders For Today and Tomorrow Anup Soans
4 Factors of Digital Transformation
1. Leadership Mindset for Digital Transformation
2. Digital Transformation - Why and How to Do it Right
3. Sales and Sales Management - Challenges & Solutions
4. Customer/Patient Centricity - Why and How to Do it Right
What is Indian Pharma Thinking about Digital? A Research ProjectAnup Soans
First Ever Indian Pharma Centric Survey: A CredoWeb India – #MedicinMan Research Project
As a part of Digital Excellence Pharma Academy , we initiated a research project with a detailed survey to understand the current status and issues faced by Indian Pharma companies in adopting digital to bridge the pharma – physicians disconnect.
You can know more about the scope and scale of this research project and survey at https://lnkd.in/gR5JMer
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramAnup Soans
Ready for the next Webinar on Digitalisation of Pharma Marketing?
Digital Excellence Pharma Academy a partnership between MedicinMan and CredoWeb not only equips pharma/devices/diagnostics/disposable company employees with KA$H (you’ll learn about KA$H soon in the future webinars), but offers you the ability to adopt the digital platform to communicate and engage your customers and create lasting experiences to build your relationship with customers.
To know more on how to engage doctors via digital, attend 40+ webinars brought to you by CredoWeb in partnership with MedicinMan - follow 3 simple steps:
Go to www.credoweb.in
Create your “Pharma professional” registration
Follow Digital Excellence Pharma Academy page and stay tuned for our webinars for which you will be cordially invited
The Mankind Pharma Story by Dr. Sumit GhoshalAnup Soans
Mankind was established in 1991, almost a decade after the industry leaders of today including Dr.Reddy’s and Sun Pharma, but has grown considerably faster than its contemporaries...
One reason for this is that unlike major drug makers who have a large portfolio of hundreds of products, mankind prefers to concentrate on a much smaller number of high value products. “they don’t bother with smaller products with a potential value of less than Rs.5 crore,” says a long-time industry watcher. thus Health OK, their OTC product, which is a combination of vitamins and nutritional medicines was able to generate Rs.50 crore in revenue within a year of its launch in 2014-15.
This is also the approach adopted by some multinationals like Sanofi, whose CEO Chris Viebacher said, that his company obtained a lion’s share of its revenue from just 15 top selling patented products...
Indian Pharma and Retail Pharmacies - Sales View PollAnup Soans
The Sales View poll concluded with valuable information on several key aspects of the Indian Pharmaceutical field force, especially in the strategies employed by medical sales reps to obtain marketing intelligence. With sales force considered to be a strong pillar of the pharmaceutical industry, gaining pointers on their day-to-day operations, and challenges faced, is indeed an asset in improving the pharma industry.
Such weekly and monthly data analysis by IQVIA and leading pharma KOLs will help you understand market dynamics better. Do participate in our polls and keep up with the latest opinions and trends on IQVIA Sales View.
Healthcare's Future will be Patient ExperienceAnup Soans
With healthcare reform now opening the door to more insured patients, it is not overwhelming what we hear nowadays that market access is dead and patient access is the new prescription for healthcare marketing.
Patient access helps when there is precariousness in the benefits, which will never be fully known until a product is used in the real world and over a period of time.
A patient access centered mindset aims to understand the patient and provider pathways, with the ultimate objective that all those patients who can optimally benefit from a product can have the access to the product.
Instead of a win/lose mindset at the core of market access, patient access tries to create win/win/win solutions that lead to value for patients, companies, and the healthcare system at large.
In such a scenario, several issues that should deal with patient access should be addressed such as:
Patient access as a guiding principle across all functions
Developing a clear and compelling value proposition for each stakeholder group
Creating a formal framework for understanding the impact of decisions on patient access
Getting payer input and advice early on
Enhanced patient satisfaction
Improved communication through shared data
Unethical Practices in Pharma - Interesting Study from Pakistan Anup Soans
This study clarifies the current pharmaceutical drug promotion and prescribing practices in Pakistan. The majority of prescribers and national pharmaceutical firms and to some extent the multinational pharmaceuticals are involved in unethical practices in drug promotion and prescribing. Alarming policies governing the drug promotion and prescribing are required to be implemented by the concerned regulatory authorities to avoid unnecessary harm to the patient’s life and pocket through the unethical drug promotion. The prescribers should not accept any incentives, gifts of financial value from any pharmaceutical companies in return for an increase in prescribing selected brand. On the other hand, pharmaceutical companies must compete in the market on the basis of the drug quality and do not offer any valuable gift and incentives to the prescribers. The interaction between doctors and phar- maceutical firms should be restricted within acceptable boundaries and the authorities must be prepared to play an active role. Strengthening the regulatory machinery and formulating policies in this regard in neces- sary. It is essential that a health care professional such as a pharmacist can play an important role in this process since he/she is an expert in the pharmaceutical field as well as more aware of the outcomes of unethical drug prescribing practices such as polypharmacy and adverse drug reactions.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
11. Doctors want
information that is
specific to their
practice
Patients want
information
tailored to their
condition
Medical Reps want
information specific to
their Doctor-pool +
L&D needs
12. 1 minute of Internet:
240 million emails
4M Google search
2.5M Facebook shares
48K app downloads
72 hours new videos
16. On Facebook
Ninety Thousand Indians use
Dr. in their Name.
In Profiles, 2,35,000 Indians
displayed MBBS as their
graduation degree.
Number of Indians with interest
of Cardiology- 40,000
Source: Via Media Health
17. 72% of Indian HCPs are Frequent Internet
Users (but do not necessarily know
where to get the best information)
20. “Perhaps the biggest challenge to integrating digital
technology into pharma’s business plans is not the
much touted ‘return on investment (RoI)’ as much as it
about transferring power out of the marketing
organization. How comfortable is the industry in
allowing its sales representatives to decide the flow of
information to its key customers in real time without
seeking approval from the hierarchy? And how
comfortable are we with interactivity? Our detailing aids
are designed to ‘push’ information. When the customer
slaps us on one cheek are we ready to turn the proverbial
other one?”
- Salil Kallianpur, Brand Director, Classic Brands Europe,
GSK in the MedicinMan Digital Special Issue
Mindset Change
21. Novartis: Putting the Rep at the Center of Digital
Strategy
Digital Pharmaceutical Company of the Year
2014 at the PM Society Digital Media Awards
Case Study 1
22.
23. “Digital is a revolution and we need to build a culture
rather than focusing too much on various apps and
gimmicks. Minimize the divide between health
professionals and patients. ”
- Sanjiv Navangul, Managing Director, Janssen India